Aug 6, 2026
The U.S. Department of Health and Human Services announced it will decertify Network for Hope, a Kentucky-based organ procurement organization, following allegations that staff continued with organ retrieval procedures despite patients showing signs of life, including a case where a patient was thrashing, crying, and shaking his head.
UK regulators have authorized the INTERCEPT-Lynch Phase 1/2 trial of mRNA-4194, a preventive cancer vaccine developed by Moderna and the University of Oxford targeting people with Lynch syndrome, an inherited condition affecting 1 in 300 people with up to 80% lifetime cancer risk. The trial will begin dosing in summer 2026.
The Centers for Medicare & Medicaid Services finalized a 2.3% payment increase for inpatient hospitals in fiscal year 2027 and introduced the first nationwide mandatory payment model for joint replacements starting in 2028. Hospital groups criticized the raise as inadequate and objected to the mandatory nature of the new model.
The Michigan Supreme Court ruled 4-3 on July 31, 2026, overturning two lower court decisions and allowing Attorney General Dana Nessel to proceed with an investigation into Eli Lilly's insulin pricing practices under the Michigan Consumer Protection Act.
The Massachusetts legislature passed legislation on the final day of formal sessions that would expand abortion access later in pregnancy by giving physicians final authority to determine medical necessity. The bill now awaits Governor Maura Healey's signature.
Multiple U.S. states are implementing measures to regulate pharmacy benefit management companies that oversee prescription drug coverage for health insurers, as part of efforts to reduce medication costs for consumers.
Elevance Health has paid the federal government more than $342 million to settle allegations that it overcharged Medicare Advantage for years. The payment comes amid an ongoing billing probe into the major insurer, which covers approximately 2 million Medicare Advantage beneficiaries.
The Centers for Medicare & Medicaid Services issued a proposed rule (CMS-2449-P) addressing Medicaid managed care state directed payments and fee-for-service targeted practitioner payments, representing significant changes to how states can direct Medicaid spending.
The Philadelphia Department of Public Health recommended patients at a Rittenhouse Square dental office get tested for Hepatitis B, Hepatitis C, and HIV after the office's license was suspended due to infection control violations.
A key GOP lawmaker is investigating whether the American Medical Association's medical billing codes are contributing to healthcare fraud, broadening Republican efforts to combat fraud in the healthcare system.
Atrium Health, one of the nation's largest hospital networks, has proposed acquiring the Raleigh-based WakeMed system. State and local officials are pressing for a delay on the deal, which became public on May 1.
The Centers for Medicare & Medicaid Services and FDA announced a new pathway to streamline Medicare coverage for breakthrough medical devices, cutting red tape and providing predictability for device manufacturers and faster patient access to life-changing technologies.
Major health care firms and trade groups are spending unprecedented amounts on lobbying as the Trump administration intensifies scrutiny of their business practices ahead of midterm elections, with new disclosures showing record first-quarter spending.
Swiss drugmaker Roche presented latest clinical trial data for its experimental multiple sclerosis drug at a major conference, setting the stage for regulatory approval submissions, though safety questions remain under scrutiny.
CVS Health's Caremark pharmacy benefits unit reached a settlement with the U.S. Federal Trade Commission to curb controversial rebate practices in the pharmacy benefits market. The agreement requires Caremark to count consumer purchases from Trump's TrumpRx program toward insurance deductibles, mirroring a similar settlement previously reached with Cigna.